Thanks for putting in that work ITM, which made it easier to understand that IMAGINE was not adequately powered to prove or disprove much at all, when addition or removal of one patient can change the result of the trial. In this case it was the trial design which failed the drug.
Progress, page-27
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $8.75K | 1.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 63306661 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28430837 | 21 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |